Search

Your search keyword '"Onchocerca volvulus physiology"' showing total 110 results

Search Constraints

Start Over You searched for: Descriptor "Onchocerca volvulus physiology" Remove constraint Descriptor: "Onchocerca volvulus physiology"
110 results on '"Onchocerca volvulus physiology"'

Search Results

1. Persistent transmission of onchocerciasis in Kwanware-Ottou focus in Wenchi health district, Ghana.

2. Ongoing transmission of onchocerciasis in the Pru District of Ghana after two decades of mass drug administration with ivermectin and comparative identification of members of the Simulium damnosum complex using cytological and morphological techniques.

3. Onchocerciasis in the Cameroon-Chad border area after more than 20 years of annual mass ivermectin distribution.

4. Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.

5. Review of epilepsy care in the Democratic Republic of the Congo.

6. Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania.

7. Multimodal biomarker discovery for active Onchocerca volvulus infection.

8. Onchocerca volvulus transmission in the Mbam valley of Cameroon following 16 years of annual community-directed treatment with ivermectin, and the description of a new cytotype of Simulium squamosum.

9. Macrophage migration inhibitory factor in Nodding syndrome.

10. Evaluating the diagnostic test accuracy of molecular xenomonitoring methods for characterising the community burden of Onchocerciasis.

11. Nodding syndrome research revisited.

12. Establishment of an in vitro culture system to study the developmental biology of Onchocerca volvulus with implications for anti-Onchocerca drug discovery and screening.

13. Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.

14. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.

15. Identification of Human-Derived Attractants to Simulium damnosum Sensu Stricto in the Madi-Mid North Onchocerciasis Focus of Uganda.

16. Prediction pipeline for discovery of regulatory motifs associated with Brugia malayi molting.

17. The insufficiency of circulating miRNA and DNA as diagnostic tools or as biomarkers of treatment efficacy for Onchocerca volvulus.

18. The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.

19. Optimization and evaluation of the Esperanza Window Trap to reduce biting rates of Simulium damnosum sensu lato in Northern Uganda.

20. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.

21. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa.

22. Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum.

23. On-going transmission of human onchocerciasis in the Massangam health district in the West Region of Cameroon: Better understanding transmission dynamics to inform changes in programmatic interventions.

24. Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study.

25. Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.

26. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.

27. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.

28. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.

29. Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness.

30. Evaluation of Community-Directed Operation of Black Fly Traps for Entomological Surveillance of Onchocerca volvulus Transmission in the Madi-Mid North Focus of Onchocerciasis in Northern Uganda.

31. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.

32. Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus .

33. Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial.

34. Onchocerciasis transmission in Ghana: the human blood index of sibling species of the Simulium damnosum complex.

35. The Imaramagambo Onchocerciasis Focus in Southwestern Uganda: Interruption of Transmission After Disappearance of the Vector Simulium neavei and Its Associated Freshwater Crabs.

36. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.

37. Evidence for Suppression of Onchocerciasis Transmission in Bioko Island, Equatorial Guinea.

38. Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.

39. Seasonal Variation in Biting Rates of Simulium damnosum sensu lato, Vector of Onchocerca volvulus, in Two Sudanese Foci.

40. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.

41. Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus.

42. Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa.

43. River Blindness: Mathematical Models for Control and Elimination.

44. Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.

45. Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial.

46. Elimination of Onchocerciasis from Mexico.

47. Potential effects of warmer worms and vectors on onchocerciasis transmission in West Africa.

48. Assessments of the transmission of Onchocerca volvulus by Simulium sanctipauli in the Upper Denkyira District, Ghana, and the intermittent disappearance of the vector.

49. Onchocerciasis transmission in Ghana: biting and parous rates of host-seeking sibling species of the Simulium damnosum complex.

50. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted.

Catalog

Books, media, physical & digital resources